A study investigating the incidence of total knee replacement subsequent to intra-articular injections of Ampion versus saline (a long-term follow-up study to a randomized controlled trial AP007)
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2018
Price : $35 *
At a glance
- Drugs DMI 9523 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Ampio Pharmaceuticals
- 05 Jun 2018 According to an Ampio media release, results from this study were published in the Patient Safety in Surgery, a peer-reviewed journal.
- 29 May 2018 New trial record
- 22 May 2018 According to the Ampio Pharmaceuticals media release, this study was accepted for publication in the peer-reviewed journal Patient Safety in Surgery.